Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Finch Therapeutcs Grp Inc (FNCH)

Finch Therapeutcs Grp Inc (FNCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Finch Therapeutcs Grp Inc 75 State Street Suite 100 Boston MA 02109 USA

www.finchtherapeutics.com P: 617-229-6499

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Finch Therapeutics Group Inc. is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery(R) platform to develop a novel class of orally administered biological drugs. The company's product candidate includes CP101, FIN-211, FIN-524 and FIN-525. Finch Therapeutics Group Inc. is based in SOMERVILLE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 11,722
Enterprise Value, $K -13,398
Shares Outstanding, K 1,606
Float, K 885
% Float 55.10%
Short Interest, K 0
Short Float 0.00%
Days to Cover 1.00
Short Volume Ratio 0.30
% of Insider Shareholders 44.90%
% of Institutional Shareholders 21.77%

Financials:

Annual Sales, $ 107 K
Annual Net Income, $ -13,880 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,830 K
EBIT, $ -17,910 K
EBITDA, $ -16,390 K

Growth:

1-Year Return -47.86%
3-Year Return -34.23%
5-Year Return -98.48%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/22/26 [--]
Earnings Per Share ttm -8.82
EPS Growth vs. Prev Year -89.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 06/12/23

FNCH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.82
Book Value/Share 8.83
Interest Coverage 0.00
60-Month Beta 1.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.